Cargando…

Using complex II as an emerging therapeutic target for the treatment of muscle lesions

After patients has been trapped into skeletal muscle injury, hypoxic and dysfunctional mitochondria brings about a crisis in energy supply that severely disrupts the repair of skeletal muscle. This study aims to elucidate injury-induced adaptations in the mitochondria and provide statistics for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kefeng, Han, Wei, Zhao, Ying, Qi, Yujuan, Li, Yadan, Bi, Jun, Wang, Yi, Dong, Guijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923501/
https://www.ncbi.nlm.nih.gov/pubmed/31889777
http://dx.doi.org/10.1016/j.sjbs.2019.07.002
_version_ 1783481548612304896
author Li, Kefeng
Han, Wei
Zhao, Ying
Qi, Yujuan
Li, Yadan
Bi, Jun
Wang, Yi
Dong, Guijun
author_facet Li, Kefeng
Han, Wei
Zhao, Ying
Qi, Yujuan
Li, Yadan
Bi, Jun
Wang, Yi
Dong, Guijun
author_sort Li, Kefeng
collection PubMed
description After patients has been trapped into skeletal muscle injury, hypoxic and dysfunctional mitochondria brings about a crisis in energy supply that severely disrupts the repair of skeletal muscle. This study aims to elucidate injury-induced adaptations in the mitochondria and provide statistics for the role of complex II in instilling cells with energy under hypoxic conditions. Fifty-six male Wistar rats were divided into control, 12 h, 2 d, 5 d, 7 d, 10 d, 15 d, and 30 d postinjury groups. Contusion injury was made via an instrumented drop-mass technique delivering single impact to the posterior surface of the gastrocnemius of one limb of the rats. ROS levels, loss of mitochondrial membrane potential (MMP), activities of marker enzymes (miCK, LDH, and ALP), and activities of complexes I–III were determined. Our findings reveal that the first 2 d postinjury, especially at 12 h, is the period with most severe oxidative stress. After injury, the activities of mitochondrial complexes I–III display different behaviors based on time and various energy production mechanisms. Our results highlight that complex II participates in electron transport in the acute phase of blunt trauma. We proposed that CII could be a therapeutic target in muscle lesions.
format Online
Article
Text
id pubmed-6923501
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69235012019-12-30 Using complex II as an emerging therapeutic target for the treatment of muscle lesions Li, Kefeng Han, Wei Zhao, Ying Qi, Yujuan Li, Yadan Bi, Jun Wang, Yi Dong, Guijun Saudi J Biol Sci Article After patients has been trapped into skeletal muscle injury, hypoxic and dysfunctional mitochondria brings about a crisis in energy supply that severely disrupts the repair of skeletal muscle. This study aims to elucidate injury-induced adaptations in the mitochondria and provide statistics for the role of complex II in instilling cells with energy under hypoxic conditions. Fifty-six male Wistar rats were divided into control, 12 h, 2 d, 5 d, 7 d, 10 d, 15 d, and 30 d postinjury groups. Contusion injury was made via an instrumented drop-mass technique delivering single impact to the posterior surface of the gastrocnemius of one limb of the rats. ROS levels, loss of mitochondrial membrane potential (MMP), activities of marker enzymes (miCK, LDH, and ALP), and activities of complexes I–III were determined. Our findings reveal that the first 2 d postinjury, especially at 12 h, is the period with most severe oxidative stress. After injury, the activities of mitochondrial complexes I–III display different behaviors based on time and various energy production mechanisms. Our results highlight that complex II participates in electron transport in the acute phase of blunt trauma. We proposed that CII could be a therapeutic target in muscle lesions. Elsevier 2019-12 2019-07-06 /pmc/articles/PMC6923501/ /pubmed/31889777 http://dx.doi.org/10.1016/j.sjbs.2019.07.002 Text en © 2019 Production and hosting by Elsevier B.V. on behalf of King Saud University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Li, Kefeng
Han, Wei
Zhao, Ying
Qi, Yujuan
Li, Yadan
Bi, Jun
Wang, Yi
Dong, Guijun
Using complex II as an emerging therapeutic target for the treatment of muscle lesions
title Using complex II as an emerging therapeutic target for the treatment of muscle lesions
title_full Using complex II as an emerging therapeutic target for the treatment of muscle lesions
title_fullStr Using complex II as an emerging therapeutic target for the treatment of muscle lesions
title_full_unstemmed Using complex II as an emerging therapeutic target for the treatment of muscle lesions
title_short Using complex II as an emerging therapeutic target for the treatment of muscle lesions
title_sort using complex ii as an emerging therapeutic target for the treatment of muscle lesions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923501/
https://www.ncbi.nlm.nih.gov/pubmed/31889777
http://dx.doi.org/10.1016/j.sjbs.2019.07.002
work_keys_str_mv AT likefeng usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions
AT hanwei usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions
AT zhaoying usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions
AT qiyujuan usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions
AT liyadan usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions
AT bijun usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions
AT wangyi usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions
AT dongguijun usingcomplexiiasanemergingtherapeutictargetforthetreatmentofmusclelesions